Lazard Asset Management »

Bridgebio Pharma shares owned by Lazard Asset Management

Quarter-by-quarter ownership of Bridgebio Pharma shares owned by Lazard Asset Management from 13F filings

Historical chart of Lazard Asset Management investment in Bridgebio Pharma

Tip: Access up to 7 years of quarterly data

All positions including Bridgebio Pharma held by Lazard Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bridgebio Pharma by Lazard Asset Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $14k 843k 0.02

More positions owned by Lazard Asset Management

Apple (AAPL)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
American Tower Reit (AMT)
Exelon Corporation (EXC)
Crown Castle Intl (CCI)
Alphabet Cap Stk Cl A (GOOGL)
Taiwan Semiconductor Manufac Sponsored Ads (TSM)
Alphabet Cap Stk Cl C (GOOG)
Canadian Natl Ry (CNI)
Broadcom (AVGO)
Ferrovial Se Ord Shs (FER)
Consolidated Edison (ED)
CSX Corporation (CSX)

View all positions for Lazard Asset Management

Top funds holding Bridgebio Pharma

D. E. Shaw & Co
Franklin Resources
OZ Management
Invesco
BlackRock
Nuveen
CSS
Alberta Investment Management Corporation
Calamos Advisors
Ameriprise Financial
Wolverine Asset Management
SSI Investment Management
Bank of America Corporation
Goldman Sachs Group
Bnp Paribas Arbitrage, Snc

View all funds holding Bridgebio Pharma